BENZOXAZINE DERIVATIVES VITRIMERS

Information

  • Patent Application
  • 20230235122
  • Publication Number
    20230235122
  • Date Filed
    June 08, 2021
    3 years ago
  • Date Published
    July 27, 2023
    a year ago
Abstract
An ester containing benzoxazine monomer and to a process for synthesizing the monomer and to vitrimers obtained through the polymerization of the ester containing benzoxazine monomer. Also, a use of the vitrimer as a reversible adhesive, sealant, coating or encapsulating systems for substrates selected from the group consisting of a metal, polymer, glass and ceramic material
Description
FIELD

The invention is directed to the field of ester-containing benzoxazine derivatives vitrimers and to a process of manufacturing thereof and the use of the vitrimers in various applications.


BACKGROUND

In almost all cases, composites are produced from thermoset resins, a material of choice for numerous applications because of their dimensional stability, mechanical properties and creep/chemical resistance. However, as a result of their permanent molecular architecture, they are impossible to recycle or to reprocess, and ends up in landfills.


A chemical way to tackle this drawback is offered by the introduction of exchangeable chemical bonds, leading to dynamic cross-links. Polymer networks containing such exchangeable bonds are also known as covalent adaptable networks (CANs) (W. Denissen et al.—Wim Denissen, Johan M. Winne and Filip E. Du Prez, Chem. Sci., 2016, 7, 30-38). CANs may be further classified into two groups depending on their exchange mechanism, either dissociative or associative. In the first, chemical bonds are first broken and then formed again at another place. Diels Alder reactions are the most common mechanism of dissociative CANs. In the second, polymer networks do not depolymerise upon heating, but are characterized by a fixed cross-link density. Covalent bonds are only broken when new ones are formed, making these networks permanent as well as dynamic. The first reported associative CANs (2005) were based on photo-mediated reactions by using allyl sulfides for instance. Later, a similar exchange mechanism was introduced by using alternative radical generators with trithiocarbonates.


In 2011, Leibler et al. (D. Montarnal, M. Capelot, F. Tournilhac and L. Leibler, Science, 2011, 334, 965-968) extended the field of associative CANs by adding a suitable transesterification catalyst to epoxy/acid or epoxy/anhydride polyester-based networks, resulting in permanent polyester/polyol networks that show a gradual viscosity decrease upon heating. Such a distinctive feature of vitreous silica had never been observed in organic polymer materials. Hence, the authors introduced the name vitrimers for those materials.


Vitrimers are portrayed as the third class of polymeric material owing to their outstanding features. The dynamic nature of the covalent network, arises from reversible chemical bonds, allows the material to be healed, recycled and reprocessed like thermoplastics. These exchange reactions are triggered by external stimulus, most frequently temperature. The viscosity of vitrimers gradually decreased upon heating providing malleability to the network while permitting internal stress to relax. Network integrity over the entire range of application ensures mechanical and solvent resistance.


Following the prototypal vitrimer developed by Leibler et al. in 2011 (previously mentioned), dynamic transesterification reactions demonstrated extensive interest over the last decade. These chemical exchanges induced at elevated temperatures between ester linkages and hydroxyl groups are responsible for topology rearrangements. Transesterification mechanism was implemented in cross-linked network to design self-healable, recyclable and reprocessable material with tunable properties.


Demongeot et al. (A. Demongeot, R. Groote, H. Goossens, T. Hoeks, F. Tournilhac and L. Leibler, Macromolecules, 2017, 50 (16), 6117-6127) adapted the vitrimer concept to commercially available thermoplastic. Cross-linked polybutylene terephthalate (PBT) vitrimer based on transesterification exchanges was successfully prepared by reactive extrusion. In addition to improving the manufacturing techniques and the potential scope of these networks, global environmental context urges the scientific community to promote sustainable polymer derived from naturally occurring feedstocks. Altuna et al. (F. I. Altuna, V. Pettarin and R. Williams, Green Chem., 2013, 15, 3360-3366) endeavoured to generate fully bio-based polyester showing properties reminiscent of vitrimers, starting from epoxidized soybean oil and an aqueous citric acid solution. Furthermore, Legrand et al. (A. Legrand and C. Soulié-Ziakovic, Macromolecules, 2016, 49, 5893-5902) enabled to extend the scalability of applications of vitrimer networks by developing a silica—reinforced epoxy vitrimer nanocomposites with enhanced properties.


Polybenzoxazines are a new type of thermoset with outstanding mechanical and thermal properties. As many other thermosets, they cannot be reshaped, re-processed nor recycled. A few examples have been reported showing a reasonable level of healability (L. Zhang, Z. Zhao, Z. Dai, L. Xu, F. Fu, T. Endo, X. Liu, ACS Macro. Lett. 2019, 8, 5, 506-511 and Arslan M., Kiskan B., Y. Yagci, Sci. Rep. 2017, 7, 5207). However, polybenzoxazine remains a class of high performance materials without any demonstration of vitrimers capabilities. Such sustainable vitrimer will widespread the use of polybenzoxazine towards smart coatings, reversible adhesives, or even recyclable matrix resins for composite materials.


SUMMARY OF THE INVENTION

The invention has for technical problem to provide a solution to at least one drawback of the above cited prior art.


For this purpose, the invention is directed to an ester containing benzoxazine monomer of formula (I)




embedded image


wherein, independently,

    • at least one R* group is present in the benzoxazine cycle, and is selected from the group consisting of H, an aliphatic C1-C6 alkyl group, OH, an aliphatic C1-C6 alkoxy group, an aliphatic C2-C6 alkenyl group, an aliphatic C1-C6 alkyl or alkoxy substituted or unsubstituted phenyl group,




embedded image




    • R is either selected from the group consisting of an aliphatic C1-C6 alkyl group, an aliphatic C1-C6 alkyl or alkoxy substituted or unsubstituted phenyl group, a C2-C6 alkenyl group, —(CH2)n3— wherein n3 is an integer from 1 to 10, —CH(aliphatic C1-C6 alkyl group), —CH(aliphatic C1-C6 alkyl or alkoxy substituted or unsubstituted phenyl group), or R is omitted;

    • R′ is selected from the group consisting of H, —(CH2)n3—OH, and







embedded image




    •  wherein n=n1=n2 and are, independently, an integer of from 1 to 3, and R, the at least one R* and n3 are as defined above;

    • R″ is an aliphatic C1-C6 alkyl group; and

    • p is an integer of from 1 to 50.





The ester-containing benzoxazine monomer of the invention is advantageously suited for obtaining polybenzoxazine derivatives vitrimers by a polymerization involving the benzoxazine ring opening and a self-polymerisation under heat, resulting to the polybenzoxazine derivatives vitrimers. Owing to the specific monomer starting product, the vitrimers of the invention exhibit self-healing, reshaping, reprocessability and recycling properties. For the rest of the document, benzoxazine vitrimers will always refer to the polymerized form of the ester-bond benzoxazine monomers. “Derivative” means any compound which derives from the benzoxazine structure and which can have some various moieties or groups not modifying the base structure.


The polybenzoxazine derivatives vitrimers properties are tightly connected to the properties of the ester-containing benzoxazine monomer.


As may be seen from formula (I), the monomer includes a benzoxazine ring moiety that allows the cross-linking of the monomer upon heating and that promotes the reprocessing of the obtained benzoxazine vitrimers thanks to the exchangeable ester bonds it forms once crosslinked. Benzoxazine gives thermosetting properties such as high-temperature and flammability performance, high strength, thermal stability, low water absorption, chemical resistance, low melt viscosities, and near-zero shrinkage.


The presence of a moiety consisting in ester bonds and free aliphatic hydroxyl groups are essential to form a dynamic and reversible network of the benzoxazine derivatives vitrimers, allowing the material to be recycled, reshaped and reprocessed. An amine terminated with a hydroxyl group allows to close the oxazine ring and allows the transesterification reactions. Accordingly, the essential features of the monomer of the invention rely on the benzoxazine-containing moiety, ester bonds and free aliphatic hydroxyl groups. The Tg of such polybenzoxazine can be of from 25° C. to 300° C.


In various instances, the p integer can be in the range of from 1 to 30, for example of from 1 to 20, for example in various instances of from 1 to 10, the ranges, independently, being selected for fine-tuning the processing temperature and relaxation of the benzoxazine vitrimers obtained through the polymerization of the monomers, and for better mechanical and thermic properties of the vitrimers.


In the context of the invention, “aliphatic” group is a linear or branched group.


At least one R* group, for example 1-3 R* group(s), can be present in the benzoxazine cycle, and the R* group is selected from the group consisting of H, an aliphatic C1-C4 alkyl group, OH, an aliphatic C1-C4 alkoxy group,




embedded image


R can either be selected from the group consisting of an aliphatic C1-C3 alkyl group, an aliphatic C1-C3 alkyl or alkoxy substituted or unsubstituted phenyl group, a C2-C4 alkenyl group, —(CH2)n3— wherein n3 is an integer from 1 to 6, —CH(aliphatic C1-C3 alkyl group), —CH(aliphatic C1-C3 alkyl or alkoxy substituted or unsubstituted phenyl group), or R can be omitted;


R′ is selected from the group consisting of H, —(CH2)n3—OH, and




embedded image


wherein n=n1=n2 and are, independently, an integer of from 1 to 3, for example are 1 or 2, and R, R* and n3 are as defined above.


The invention also relates to a process for synthesizing an ester-containing benzoxazine monomer of formula (I) comprising the following steps consisting of:

    • a) reacting a phenolic acid derivative of formula (II), comprising at least one R* group,




embedded image


with a polyfunctional molecule or oligomer of formula (III)




embedded image




    • at a temperature of from 25° C. to 200° C., during 1 h-72 h, in the presence of a catalyst of Bronsted acid type, resulting in a phenol terminated oligomer or molecule of formula (IV)







embedded image




    • and

    • b) reacting the compound of formula (IV) with a mixture of:
      • an amino-alcohol bifunctional derivative of formula (V):







embedded image







      • an aldehyde derivative,







at a temperature range of from 25° C. to 100° C., during 0.5 h to 48 h, wherein R, R′, R″, the at least one R*, n, n1, n2, p are, independently, as defined above, with the proviso that when the at least one R* of the phenolic acid derivative is in ortho position with regard to —OH group, then R* is H.


The ester-containing benzoxazine monomer of the invention is advantageously suited for obtaining polybenzoxazine derivatives vitrimers by a polymerization involving the benzoxazine ring opening and a self-polymerisation under heat.


The present disclosure shows that the specific starting reactants are providing an ester-containing benzoxazine monomer, which in turn, after polymerization, is giving the polybenzoxazine derivatives vitrimers comprising polymerized benzoxazine.


“Derivative” in the expressions “phenolic acid derivative”, “amino-alcohol bifunctional derivative” and “aldehyde derivative” means any compound which respectively has/bears a phenolic acid, an amino-alcohol bifunctional and aldehyde base structure.


The benzoxazine ring, obtained from the reaction of the specific derivatives (formulae (II)-(V)) which allows the material to be cross-linked (processed) upon heating, helps the reprocessing thanks to the exchangeable and reversible ester bonds, and free aliphatic hydroxyl groups. Also, the benzoxazine ring moiety gives thermosetting properties such as high-temperature and flammability performance, high strength, thermal stability, low water absorption, chemical resistance, low melt viscosities, and near-zero shrinkage.


Accordingly, the first step of ester-containing benzoxazine monomer synthesis (step a)) typically corresponds to a Fischer esterification between a polyfunctional molecule or oligomer (ditelechelic), terminated with aliphatic hydroxyl group, of formula (III), and a phenolic acid derivative of formula (II) in presence of a Bronsted acid type catalyst which can be introduced in catalytic amount.


The phenolic acid derivative (formula (II)) can include at least one R* group, for example of from 1 to 3, related to the substitution of the phenolic ring, and the R group related to the nature of the bridge between the ester bonds and the phenolic ring.


It is advantageous that the phenolic acid derivative (formula (II)) bears R* groups that does not interfere with the phenolic ortho-position to avoid steric hindrance that can adversely impact the kinetic of step a) or the oxazine ring closure of step b). Accordingly, R* groups can then be short chain groups with the proviso that R* in phenolic ortho-position is H.


In some embodiments, there could be two phenolic ortho-positions, each of which is H for the R* group.


The phenolic acid derivative can in various instances be an aliphatic or an aromatic phenolic acid, or combination thereof.


The phenolic acid derivative can be for example selected from the group consisting of mono-, di-, tri-hydroxybenzoic acid derivatives, anacardic acid derivatives, hydroxycinnamic acid derivatives, aliphatic X-hydroxyphenyl acid derivatives, wherein X is 2-4, aliphatic diphenolic acid derivatives and triphenolic acid derivatives, or mixtures thereof. However, the triphenolic acids are the less preferred due to the steric hindrance.


In various instances aliphatic mono-, di-, tri-hydroxybenzoic acid derivatives can be of formula (VI)




embedded image


wherein R is omitted, and at least one of R1 to R5 corresponds to R*, and at least one among R1-R5 is selected from the group consisting of 1, 2 and 3 hydroxyl group(s), then at least one H is in phenolic ortho-position, the rest being at least one of H and an aliphatic alkyl group of C1-C6.


Especially, in formula (VI), at least one combination of R1 to R5 can be selected from the group consisting of:


R1═OH, R2═H, R3═R4═R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R2═OH, R1═R3═H, R4═R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R3═OH, R2═R4═H, R1═R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R4═OH, R3═R5═H, R1═R2═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R1═R2═OH, R3═H, R4═R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R1═R3═OH, R2═R4═H, R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R1═R4═OH, R2═R3═R5═H


R1═R5═OH, R2═R4═H, R3═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R2═R3═OH, R1═R4═H, R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R2═R4═OH, R1═R3═R5═H


R1═R3═R5═OH, R2═R4═H,


and


R2═R3═R4═OH, R1═R5═H.


In various instances anacardic acid derivatives can be of formula (VII), wherein R6═R*




embedded image


wherein R is omitted, and R6 is




embedded image


In various instances hydroxycinnamic acid derivatives can be of formula (VIII)




embedded image


wherein at least one of R1 to R5 corresponds to R*, and at least one among R1-R5 can be selected from the group consisting of 1 and 2 hydroxyl group(s) and at least one H being in phenolic ortho-position, the rest being at least one of H and an aliphatic alkyl or alkoxy group of C1-C6.


Especially, in formula (VIII), at least one combination of R1 to R5 can be selected from the group consisting of:


R5═OH, R4═H, R1═R2═R3═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R4═OH, R3═R5═H, R1═R2═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R3═OH, R2═R4═H, R1═R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2,


R3═OH, R2═O(C1-C6 alkyl group), R1═R4═R5═H, and


R2═R3═OH, R1═R4═H, R5═H or CH3 or CH2—CH3 or CH2—CH2CH3 or CH2—CH(CH3)2.


In various instances aliphatic X-hydroxyphenyl acid derivatives can be selected from the group consisting of aliphatic di-hydroxyphenyl acids (X=2), aliphatic tri-hydroxyphenyl acids (X=3) and aliphatic tetra-hydroxyphenyl acids (X=4), or mixtures thereof, of formula (IX)




embedded image


wherein

    • R7, corresponding to R, independently of the nature of X-hydroxyphenyl aliphatic acid derivatives, is selected from the group consisting of (CH2)n4, CH(CH2)n5-(aliphatic C1-C6 alkyl or alkoxy substituted or unsubstituted phenyl group), wherein n4 is an integer from 1 to 12, in various instances from 1 to 10, n5 is an integer from 0 to 12, for example from 0 to 10, CH(CH2)n5(CH3), CH(CH(CH3)2), C(CH3)2, CH(aliphatic C1-C6 alkyl or alkoxy substituted or unsubstituted phenyl group);
    • the number of R* in the ring is depending on the number of hydroxyl groups in the ring, and at least one R*, in various instances of from 1 to 3, is H towards the phenolic ortho-position, and, independently, is selected from the group consisting of (CH2)n4CH3, (CH2)n4-(aliphatic C1-C6 aliphatic alkyl or alkoxy substituted or unsubstituted phenyl group), wherein na is an integer from 1 to 12, in various instances from 1 to 10, for example 1-6, and (CH2)n4(CH(CH3)2); and
    • the integer q is comprised between 1 and 3.


When n5 is 0, the (CH2) group is omitted.


In various instances diphenolic acid derivatives are of formula (X)




embedded image


wherein


on each respective phenolic cycle, at least one R*, in various instances of from 1 to 3, is H towards the phenolic ortho-position, and otherwise R* and R2, independently, are selected from the group consisting of (CH2)n4CH3, (CH2)n4-(aliphatic C1-C6 aliphatic alkyl or alkoxy substituted or unsubstituted phenyl group), wherein n4 is an integer from 1 to 12, in various instances from 1 to 10, for example from 1 to 6, and (CH2)n4(CH(CH3)2), and R1 is selected from the group consisting of (CH2)n5, wherein n5 is an integer from 1 to 3, CH(CH2)n5(CH3), CH(CH(CH3)2) and C(CH3)2, (CH2)n5 being the most preferred to lower the steric hindrance.


In the diphenolic acid derivatives, R═—R1—C—R2— moiety. Most preferred is the 4,4-bis(4-hydroxyphenyl)valeric acid (VA).


The polyfunctional molecule or oligomer compound of formula (III) is of importance for selecting the processing temperature of the benzoxazine polymer.


The compound of formula (III) can advantageously have 1-30, better 1-20, especially 1-10, p values, and can represent for example, when R′═H, a polyethylene glycol (PEG) with a molecular weight (MW) in the range of from 4 MW of the C2H4O unit to 50 MW of the C2H4O unit, the MW of the C2H4O unit being classically of about 44.05 g/Mol. In various instances commercially available PEG is used, for example PEG 200 to PEG 2200, as being easily available.


In the compound of formula (III), when R′═H, p values can be of from 1 (ethylene glycol) to 3 (triethylene glycol—TEG).


In some other embodiments, the compound of formula (III) can be glycerol (R′═CH2OH).


The Bronsted acid type catalyst are those commonly used for a Fischer esterification include para-toluene sulfonic acid (APTS), anhydrous chlorhydric acid (HCl), phosphoric acid (H3PO4), methanoic acid (CH3—CO2H), sulfuric acid, tosylic acid, and Lewis acids such as scandium(III) triflate. The content of catalyst is of from 0.5 wt % to 2 wt %.


The step a) can advantageously be carried out at a temperature in the range of 60° C. to 150° C., for example of from 100° C. to 140° C. for the best synthesis yields of higher than 95%, the chosen temperature being dependent on the nature of the reactants, i.e. the melting temperature of the reactant medium.


Advantageously, step a) is performed of from 12 h to 48 h for the highest yield of at least 95%, and the duration is based on the kinetic of the reaction.


The respective stoichiometry of starting reactants on step a), phenolic acid derivative:polyfonctional molecule or oligomer can in various instances be 1.0-3.0 eq.:1.0 eq, resulting in an 1.0 eq. of phenol terminated oligomer or molecule.


The second step of the process, step b), corresponds to a Mannich condensation type reaction of the phenol terminated oligomer or molecule of step a) (formula IV) with an amino-alcohol bifunctional derivative (formula (V)) and an aldehyde derivative, optionally in presence of a catalyst. Thus, since step b) does not use a catalyst, step b) is implemented in an easier way.


Advantageously, the amino-alcohol bifunctional derivative of formula (V) includes a linear amino-alcohol derivative with a primary amine moiety and an aliphatic hydroxyl moiety for obtaining with the highest yield and the best reaction conditions the oxazine ring.


The amino-alcohol bifunctional derivative of formula (V) can for example be selected from the group consisting of 2-aminoethanol, 2-amino-2-methylpropanol, 5-aminopentan-1-ol, heptaminol and diglycolamine.


In various instances, the aldehyde derivative is selected from the group consisting of formaldehyde, paraformaldehyde of formula




embedded image


where m is an integer of from 8 to 100,


acetaldehyde, propionaldehyde, butylaldehyde, polyoxymethylene and aldehydes having the general formula R9CHO, where R9 is a substituted or unsubstituted aliphatic C1-C20 alkyl group optionally containing heteroatoms, or mixtures thereof. In the aldehyde derivative, R9 can in various instances be a substituted or unsubstituted aliphatic C1-C15 alkyl group optionally containing heteroatoms, such as N, O, S, for example R′ can be a substituted or unsubstituted aliphatic C1-C8 alkyl group optionally containing the optional heteroatoms.


The temperature range of step b) can in various instances be of from 75° C. to 100° C., for example of from 75° C. to 95° C. allowing to obtain the highest conversion yields of at least 95%.


Advantageously, step b) is performed from 1 h to 12 h, for example of from 2 h to 4 h for the highest yield of at least 95%.


One advantage of the invention, is that step b) is performed without any catalyst.


However, several catalysts can be used to catalyze the transesterification reaction (step b)), the catalysts being selected from the group consisting of Zn(II)(R10)2 wherein R10 can in various instances be Cl, CH3CO2, CH3—C(═O)—O, CH3COCHCOCH3, CH3(CH2)r:1-15CH2CO2; triazobicyclodecene (TBD); triphenylphosphine (PPh3) and para-toluene sulfonic acid (APTS). It should be noticed that the presence of the catalyst slightly provided a better char yield (flame resistance) of the obtained benzoxazine monomer. This enhanced char yield can be of from 15% to 30%. The content of catalyst can be of from 0.5 wt % to 2 wt %.


The respective stoichiometry of starting reactants on step b), phenol terminated oligomer or molecule: amino-alcohol bifunctional derivative: aldehyde derivative can in various instances be 1.0 eq.:1.0-18.0 eq:2.0-36.0 eq, resulting in an 1.0 eq. of the ester-containing benzoxazine monomer.


The specific range stoichiometry is depending on the respective functionality degree of the amino-alcohol bifunctional derivative and of the aldehyde derivative. Besides, the selected stoichiometry ranges of both amino-alcohol bifunctional derivative and aldehyde derivative in various instances avoids the formation of either reaction linear and/or aliphatic by-products, such as oxazolidine, triaza derivatives, or condensation derivatives.


In various instances, the whole process is performed with bio-based reactants.


The monomer synthesis can for example be solventless, even though a solvent could be added for the dissolution of starting reactants. The process involves a one-step synthesis, which is one of the advantages of the invention.


Advantageously, the whole synthesis can generally not require any further monomer purification for the invention to be implemented. However, the purification of the monomer, if needed, can be performed by any known technic (vacuum, distillation etc.)


The reaction mixtures of both steps a) and b) are stirred using a classical mechanical stirrer, or any non-limitative means.


The process can be implemented by any known means known to the one skilled in the art, using appropriate vessel either at lab scale or at industrial scale.


The invention also relates to a process for preparing a polybenzoxazine derivative vitrimer comprising the step of polymerization of an ester-containing benzoxazine monomer of the invention or as obtainable by the above mentioned process at temperatures within the range of from 100° C. to 250° C. for 1 h to 24 h, for obtaining polybenzoxazine derivatives vitrimers.


According to the process for preparing the vitrimers of the invention, the polymerization step, which is a curing step, allows the benzoxazine ring to open and to react on itself to form a 3D network. Once cooled, the shape of the material is kept even after few months, typically 2-4 months. Once re-heated to at least 100° C. for a few minutes, the ester bonds are exchanging with the aliphatic hydroxyl group allowing the material to be reshaped, recycled, or reprocessed; while keeping structural integrity and number of covalent bound. Considering that Mannich condensation reaction is quantitative, nearly two hydroxyls groups could react with each ester bound through transesterification reaction (even after curing). The vitrimer behaviour strongly depend on the vitrimer glass transition (Tv) also considered as the temperature where the transesterification reaction significantly increased. The vitrimer behaviours were demonstrated through several experiments. After the curing step, by heating the vitrimer above the Tv, an initial shape of the vitrimer can be designed to other original shape. For example, vitrimers can be ground to a powder and can be reshaped or reprocessed at 150° C. in a couple of minutes. However its shape remains stable at room temperature.


The polymerization duration is depending on the curing temperature and/or on the nature of the ester-containing benzoxazine monomer. The polymerization temperature is selected for a given monomer to be higher than the temperature needed to synthesize the monomer. Generally, the higher the polymerization temperature, the shorter the curing duration. For example, when the temperature of the polymerization is 250° C., the curing duration can be of at least 1 h, and for a polymerization temperature of 100° C., the curing duration can be of no more than 24 h. in various instances, the curing temperature can be of from 140° C. to 200° C., for example of from 140° C. to 180° C., the latter range providing curing duration of from 1.5 h to 3 h, in various instances of from 1.5 h to 2.5 h. The polymerization can be performed by any known heating means, such as laser beam and infrared beam.


The process can also include a post-polymerization step consisting of a heating step which can in various instances be carried out at higher temperature than that the polymerization heating step.


The invention is also directed to a polybenzoxazine derivative vitrimer, that can be obtained by the above depicted process, exhibiting at least one of the following characteristics:

    • (i) Tv values of from 120° C. to 220° C.; in various instances of from 150° C. to 200° C., for example of from 150° C. to 170° C., and
    • (ii) Relaxation temperature values, ≥Tv values, of from 120° C. to 270° C., in various instances of from 150° C. to 200° C., for example of from 150° C. to 180° C.


The vitrimers Tv values are generally dependent from the nature and the content of the catalyst of step b), when present.


The relaxation temperatures typically correspond to the relaxation temperatures of the vitrimers after the appliance of a strain, for example a physical deformation such as a torsion, without the observation of vitrimers degradation.


Advantageously, the vitrimers can also exhibit at least one of the following characteristics selected from the group consisting of:

    • a relaxation time of from 0.5 s to 2 h, in various instances of from 1 s to 1 h, for example of from 5 s to 50 min. The relaxation time is conventionally defined as the time for the sample to relax to a value corresponding 1/e (0.37) of its original modulus Generally, the higher is the temperature, the shorter is the relaxation time. For example, the relaxation time is about 5 min-20 s at temperatures values of 120° C.-150° C., and of ≤20, in various instances 5 s-20 s, at temperature ranges of 150° C. to 200° C.


In some embodiments, the vitrimer can be deformed between 0.1% to 100% of its initial size;

    • an activation energy related to relaxation times can be of from 50 kJ/mol to 200 kJ/mol, in various instances of from 70 kJ/mol to 170 kJ/mol, for example of from 100 kJ/mol to 160 kJ/mol; and
    • a processing temperature can be of from 100° C. to 250° C., in various instances of from 130° C. to 250° C., for example of from 150° C. to 200° C., for example of from150° C. to 170° C.


The vitrimers according to the invention can also in various instances exhibit the characteristics of behaving as a thermoset and/or an insolubility in many solvents, without been limited, such as water, CHCl3, CH2Cl2, DMF, THF, aromatic solvents, such as toluene and/or xylene, ketones, alcohols or carboxylic acids. Swelling properties are observed as an extent of from 0 to 500% of the initial weight thereof. Swelling experiments can be carried out in various solvents, for example in acetone, chloroform and water to assess the formation of a cross-linked network. Among them, chloroform is one of the solvents in which the vitrimer can show the highest swelling ratio of about 100%. In acetone and water, some vitrimers swell of 40%-50% and 20%-30%, respectively. Some other vitrimers can show swelling properties in water of 150% to 230%.


The vitrimers of the invention present self-healing, reshaping, reprocessability, recycling and reversible adhesive properties.


The vitrimers can constitute an intermediate layer between at least two substrates, such as metal, polymer, glass and ceramic material. The resulting composite material can be prepared by setting at least one ester-containing benzoxazine monomer between the two considered substrates then curing at a temperature providing the vitrimer without altering the integrity of the substrates. Each substrate can be different from the other.


Metallic substrates are not limited, and can be of aluminium, iron, steel and the like.


Polymer substrates can be of polycarbonate, acrylic, polyamide, polyethylene or terephthalate.


Benzoxazine vitrimers can then be advantageously used in non-limited various fields of technologies, such electronics, aerospace, defense and automotive fields.


The invention also relates to a composition A comprising:

    • a) an ester-containing benzoxazine monomer of formula (I), and
    • b) at least one or more additional compounds of organic molecules types containing or not benzoxazine moieties.


In various instances, the organic molecules types can be polymers containing or not benzoxazine moieties.


The additional compound can be used to enhance the properties of either the monomer or the vitrimer (i.e. viscosity, mechanical and thermal properties), or both.


Polymers can be epoxy resins, bismaleimide resins, phenolic resins or benzoxazine resins, polyurethanes, polyamides, polyolefins, polyesters, rubbers. The ester-containing benzoxazine derivative of formula I can be used in a weight ratio from 0.1 to 80% of the final composition.


The compound of formula I can be used to provide vitrimer properties to the above mentioned polymers (self-healing, reprocessing, etc.).


The invention also relates to a composition B comprising:

    • a) an ester-containing benzoxazine monomer of formula (I), and
    • b) a material selected from the group consisting of fillers, fibers, pigments, dyes, and plasticizer.


The additional compound can be used to enhance the properties of either the monomer or the vitrimer (i.e. viscosity, mechanical and thermal properties), or both.


The additional compound could be carbon fibers, glass fibers, clays, carbon black, silica, carbon nanotubes, graphene, any known means for the thermal or the mechanical reinforcement of composites.


The invention also concerns a use of the vitrimer according to the invention as a reversible adhesive, sealant, coating or encapsulating systems for substrates selected from the group consisting of a metal, polymer, glass and ceramic material. In various instances, the metal and the polymer are as above defined.


The invention also relates to a use of the vitrimer according to the invention in 3D printing processes or in additive manufacturing processes.





DRAWINGS

Other features and advantages of the present invention will be readily understood from the following detailed description and drawings among them:



FIG. 1 exemplarily shows a synthesis reaction of an ester-containing benzoxazine monomer from 4,4-Bis(4-hydroxyphenyl)valeric acid (DPA) as a phenolic acid derivative, in accordance with various embodiments of the invention.



FIG. 2 exemplarily shows a network for a vitrimer obtained through the curing of the valeric acid benzoxazine monomer (schematized form), in accordance with various embodiments of the invention.



FIG. 3 is an exemplary NMR spectrum of the valeric acid derivative benzoxazine monomer (PEG-DPA-mea), in accordance with various embodiments of the invention.



FIG. 4a) exemplarily displays the DSC curve and FIG. 4b) the TGA of valeric acid benzoxazine monomer, in accordance with various embodiments of the invention.



FIG. 5 exemplarily illustrates the ability of the vitrimer of FIG. 2 to be reshaped and reprocessed, in accordance with various embodiments of the invention.



FIG. 6a) exemplarily displays a Dilatometry curve (dL/L0 (%) vs temperature) of the vitrimer obtained through the curing of the valeric acid benzoxazine monomer, the latter obtained without the use of any catalyst or with the use of 2% Zn(OAc)2 catalyst in step b); and FIG. 6b) exhibits the mechanical properties of the vitrimer, in accordance with various embodiments of the invention.



FIG. 7a) exemplarily depicts shear stress relaxation experiments: normalized relaxation modulus as a function of time between 120° C. and 170° C.; FIG. 7b): Arrhenius plot of the measured relaxation times for the vitrimer of FIG. 2, in accordance with various embodiments of the invention.



FIG. 8a) and FIG. 8b) are exemplary respectively displaying the NMR spectrum of the valeric acid benzoxazine monomers (PEG200-DPA-mea and PEG2000-DPA-mea), in accordance with various embodiments of the invention.



FIG. 9 exemplarily displays the DSC curve of PEGn-DPA-mea ester-containing benzoxazine monomers (n=200 and 2000), in accordance with various embodiments of the invention.



FIG. 10 exemplarily shows the Isothermal rheology monitoring of PEGn-DPA-mea ester-containing benzoxazine monomers (n=200 and 2000), in accordance with various embodiments of the invention.



FIG. 11 exemplarily displays Dilatometry curves of PEGn-DPA-mea ester-containing benzoxazine monomers (n=200 or 2000), in accordance with various embodiments of the invention.



FIGS. 12a) and 12b) are exemplary respectively showing Stress relaxation curves of poly(PEG200-DPA-mea) and poly(PEG2000-DPA-mea) ester-containing benzoxazine vitrimers, in accordance with various embodiments of the invention.



FIG. 13 exemplarily shows the Arrhenius plot of poly(PEGn-PA-mea) ester-containing benzoxazine vitrimer, in accordance with various embodiments of the invention.



FIG. 14 exemplarily displays the NMR spectrum of PEG400-PA-mea ester-containing benzoxazine monomer (PA: phloretic acid), in accordance with various embodiments of the invention.



FIG. 15 exemplarily displays DSC curve of PEG400-PA-mea ester-containing benzoxazine monomer (PA: phloretic acid), in accordance with various embodiments of the invention.



FIG. 16 exemplarily shows Isothermal rheology monitoring of PEG400-PA-mea ester-containing benzoxazine monomer (PA: phloretic acid), in accordance with various embodiments of the invention.



FIG. 17a) exemplarily illustrates stress relaxation curves and b) Arrhenius plot of poly(PEG400-PA-mea) ester-containing benzoxazine vitrimer (PA: phloretic acid), in accordance with various embodiments of the invention.





DETAILED DESCRIPTION
Example 1
Synthesis of an Ester-Containing Benzoxazine Monomer from 4,4-Bis(4-hydroxyphenyl)valeric Acid (DPA) as a Phenolic Acid Derivative

Ester-containing benzoxazine monomer was synthesized in two stages (FIG. 1).


The first step, step a), corresponds to a Fischer esterification between polyethylene glycol (PEG) (Mn=400 g·mol−1, p=8-9, 1 eq, 10 g) and 4,4-Bis(4-hydroxyphenyl)valeric acid (DPA) (2 eq, 14.32 g) in presence of p-toluene sulfonic acid (pTSA) introduced in catalytic amount (1 wt %). PEG, DPA and pTSA were reacted together in melt at 130° C. and agitated by mechanical stirring for 24 hours, to provide 4,4-Bis(4-hydroxyphenyl)valeric ester terminated polyethylene glycol (PEG-DPA).


The second step, step b), corresponds to a Mannich condensation between 4,4-Bis(4-hydroxyphenyl)valeric ester terminated polyethylene glycol (PEG-DPA) (1 eq, 22.8 g), ethanolamine (mea) (4 eq, 5.95 g) and paraformaldehyde (PFA) (8 eq, 5.84 g). In some examples, step b), is performed in presence of 2 wt % of Zn(OAc)2 catalyst. All these reactants were reacted together in melt at 85° C. and agitated by mechanical stirring for 2 hours to provide the ester-containing benzoxazine monomer named PEG-DPA-mea.


The FIG. 3 is displaying the NMR spectrum (AVANCE III HD Bruker spectrometer) of PEG-DPA-mea ester-containing benzoxazine monomer synthesized in presence of 2 wt % of Zn(OAc)2 catalyst in step b).



FIGS. 4a) and 4b) are respectively displaying the DSC and the TGA curves of the PEG-DPA-mea monomer in the presence (solid line) or in the absence (dash line) of Zn(OAc)2 catalyst. Conditions: 10° C. min−1, N2 atmosphere.


The DSC curve (FIG. 4a) (Netzsch DSC 204 F1 Phoenix apparatus) shows an exothermic peak starting at a temperature of 105° C., with a maximum located at 174° C. This peak corresponds to the ring opening of the benzoxazine rings upon heating. The second peak corresponds to the thermal decomposition of the ester linkage confirmed by TGA experiment (FIG. 4b)(mass loss≈6%). The second degradation stage is very similar to both samples with a weight loss of 46.7% and a maximum degradation temperature around T32 379° C. However, it should be noticed that the presence of catalyst slightly provided a better char yield (25.1%). At this stage, the material is therefore considered thermally stable up to at least 250° C. (Td5%).


Example 2
Synthesis of a Vitrimer Obtained Through the Curing of the PEG-DPA-mea Monomer

The benzoxazine monomer obtained in Example 1 was polymerized in a Teflon® mold at 150° C. during 1 h, allowing the benzoxazine rings to open and to react on themselves to form a 3D network vitrimer (FIG. 2). Once cooled, the shape of the material is kept even after few months. Once re-heated to at least 100° C. for a few minutes, the ester bonds are exchanging with the aliphatic hydroxyl group allowing the material to be reshaped, recycled, or reprocessed; while keeping structural integrity and number of covalent bound. Considering that Mannich condensation reaction was quantitative, nearly two hydroxyls groups could react with each ester bound through transesterification reaction (even after curing). The vitrimer behaviour strongly depend on the vitrimer glass transition (Tv) also considered as the temperature where the transesterification reaction significantly increased. The vitrimer behaviour of these samples was demonstrated through several experiments. After the curing step, by heating this material above the Tv, the initial rod shape of the material can be designed to other original shape. Finally, the materials were ground to a powder and can be reshaped or reprocessed at 150° C. in a couple of minutes. However, its shape remains stable at room temperature as reported in FIG. 5.


Swelling experiments were performed in acetone, chloroform and water to assess the formation of a cross-linked network of the vitrimer obtained through the curing of the PEG-DPA-mea monomer. Chloroform was the highest solvent in which the vitrimer showed the highest swelling ratio (≈100%). In acetone and water, vitrimers samples swell of 40 and 20%, respectively.


The material reacted with acetic acid to form an orange turbid suspension. The chemical decomposition of thermosets is an interesting recycling process.


Dilatometry experiments is a classical tool to reveal glass transition (Tg) and the vitrimer glass like transition (Tv) of a vitrimer.


The device used is the Netzsch DIL 402 C apparatus with experimental conditions of 2° C. min−1, N2 atmosphere.


Two vitrimer samples were used, one obtained through the curing of PEG-DPA-mea monomer without the use of any catalyst in step b) (dash line) and the second one with the use of 2% Zn(OAc)2 catalyst in step b) (solid line), results are depicted in FIG. 6. The plateau observed in for the catalyzed system is characteristic of the glass-like nature of the Tv.


Mechanical properties were determined by rheological measurements recorded on Anton Paar Physica MCR 302 rheometer in rectangular-torsion mode with experimental conditions of γ=0.1% constant deformation, f=1 Hz. The Tgs determined from the maximum in the loss modulus (G″) and the maximum of the loss factor (tan δ) are 59 and 93° C. respectively.


Viscoelastic properties of PEG-DPA-mea vitrimer were studied by stress relaxation experiments (FIG. 7a). The relaxation time of the polymer was clearly noticeable and proportionally decreasing upon heating from 120° C. (320 min) to 170° C. (94 s).


The temperature dependence of the relaxation time is plotted in FIG. 7b) following the Arrhenius law. The trend line in this plot fit to a thermally activated behavior for the relaxation time. The high correlation coefficient (R2=0.987) means that these data are perfectly fitting the Arrhenius law. The activation energy from the Arrhenius equation was extracted using the slope of the trend line. The activation energy obtained from stress relaxation for PEG-DPA-mea vitrimer is 155 kJ·mol−1.


Example 3
Synthesis of an Ester-Containing Benzoxazine Monomer from 4,4-Bis(4-hydroxyphenyl)valeric Acid (DPA) as a Phenolic Acid Derivative and Different Molecular Weight of Poly(ethylene glycol) (PEG) Solutions

The first step, step a), corresponds to a Fischer esterification between polyethylene glycol (PEGn) (Mn=200 or 2000 g·mol−1, p=4-5 or 45-46 respectively, 1 eq, 10 g) and 4,4-Bis(4-hydroxyphenyl)valeric acid (DPA) (2 eq, 28.63 and 2.86 g, respectively for PEG200 and PEG2000) in presence of p-toluene sulfonic acid (pTSA) introduced in catalytic amount (1 wt %). PEGn, DPA and pTSA were reacted together in melt at 130° C. and agitated by mechanical stirring for 24 hours, to provide 4,4-Bis(4-hydroxyphenyl)valeric acid terminated polyethylene glycol (PEGn-DPA, wherein n=200 or 2000).


The second step, step b), corresponds to a Mannich condensation between 4,4-Bis(4-hydroxyphenyl)valeric ester terminated polyethylene glycol (PEGn-DPA) (1 eq, 25 mmol, 18.2 or 63.1 g, respectively for PEG200 and PEG2000), ethanolamine (mea) (4 eq, 100 mmol, 6.11 g) and paraformaldehyde (PFA) (8 eq, 200 mmol, 6.0 g). All these reactants were reacted together in melt at 85° C. and agitated by mechanical stirring for 2 hours to provide the ester-containing benzoxazine monomer named PEGn-DPA-mea. The reaction product was used without further purifications for the elaboration of vitrimer materials.


The FIG. 8a) and FIG. 8b) are respectively displaying the NMR spectrum (AVANCE III HD Bruker spectrometer) of PEG200-DPA-mea and PEG2000-DPA-mea ester-containing benzoxazine monomers.



FIG. 9 is displaying the DSC curves of the PEG200-DPA-mea and PEG2000-DPA-mea monomers. Conditions: 10° C. min−1, N2 atmosphere (Netzsch DSC 204 F1 Phoenix apparatus). The DSC curve shows an exothermic peak starting at a temperature of 105 and 120° C. for PEG200-DPA-mea and PEG2000-DPA-mea, respectively. This peak corresponds to the ring opening of the benzoxazine rings upon heating. The second peak corresponds to the thermal decomposition of the ester linkage.


The curing of the PEGn-DPA-mea ester-containing benzoxazine monomers was monitored by rheological measurement depicted in FIG. 10, to assess the mechanical behaviour of the monomers during the curing process.


The rheogram is performed under the following conditions: 1 Hz, with linear amplitude from 1 to 0.1%; 25 mm plates. The test is performed following a heating ramp from 80° C. to 140° C. at 15° C./min followed by an isothermal measurement at 140° C. The storage and loss modulus are recorded as a function of time. The term “gelation time” is defined as the time when the storage and the loss modulus of the soften monomer increases abruptly to transform into a gel. The gelation is defined by the crossover point between the storage and the loss modulus. At 140° C., the gelation time is reached after 116 s and 864 s, respectively for PEG200 and PEG2000.


Example 4
Synthesis of a Vitrimer Obtained Through the Curing of PEGn-DPA-mea Ester-Containing Benzoxazine Monomers

The benzoxazine monomers obtained in Example 3 was polymerized in a Teflon mold at 150° C. during 1 h for the obtention of a PEGn-DPA-mea derivatives polybenzoxazine vitrimer material (n=200 or 2000).


Swelling experiments were performed in water to assess the formation of a cross-linked network of the vitrimer obtained through the curing of the PEGn-DPA-mea monomer. Vitrimers samples swell of 10% and 200%, respectively for PEG200 and PEG2000.


Dilatometry thermograms of the vitrimer samples are reported in FIG. 11. The device used is the Netzsch DIL 402 C apparatus with experimental conditions of 2° C. min1, N2 atmosphere. The first plateau corresponds to the Tg of material while the second is characteristic of the glass-like nature of the Tv.


Viscoelastic properties of poly(PEGn-DPA-mea) vitrimer were studied by stress relaxation experiments (FIG. 12a): poly(PEG200-DPA-mea) vitrimer and FIG. 12b): poly(PEG2000-DPA-mea) vitrimer). The relaxation time of the polymer was clearly noticeable and proportionally decreasing upon heating from 150° C. (814 s) to 170° C. (208 s) for PEG200-DPA-mea and from 130° C. (315 s) to 150° C. (36 s) for PEG2000-DPA-mea.


The temperature dependence of the relaxation time was plotted following the Arrhenius law in FIG. 13. The trend line fits to a thermally activated behaviour for the relaxation time. The high correlation coefficient (R2=0.9996 and 0.9817 respectively for PEG200 and PEG2000) means that these data are perfectly fitting the Arrhenius law. The activation energy from the Arrhenius equation was extracted using the slope of the trend line. The activation energy obtained from stress relaxation is 106 and 154 kJ·mol−1 respectively for poly(PEG200-DPA-mea) and poly(PEG2000-DPA-mea) vitrimer.


Example 5
Synthesis of a Benzoxazine Monomer from Phloretic Acid as a Phenolic Acid Derivative

The first step, step a), corresponds to a Fischer esterification between polyethylene glycol (PEG400) (Mn=400 g·mol−1, p=8-9, 1 eq, 10 g) and phloretic acid (PA) (2 eq, 8.31 g) in presence of p-toluene sulfonic acid (pTSA) introduced in catalytic amount (1 wt %). PEG400, PA and pTSA were reacted together in melt at 110° C. and agitated by mechanical stirring for 24 hours, to provide phloretic acid terminated polyethylene glycol (PEG400-DPA).


The second step, step b), corresponds to a Mannich condensation between phloretic acid terminated polyethylene glycol (PEG400-PA) (1 eq, 17.3 g), ethanolamine (mea) (2 eq, 3.04 g) and paraformaldehyde (PFA) (4 eq, 2.98 g). All these reactants were reacted together in melt at 85° C. and agitated by mechanical stirring for 2 hours to provide the ester-containing benzoxazine monomer named PEG400-PA-mea. The reaction product was used without further purifications for the elaboration of vitrimer materials.



FIG. 14 is displaying the NMR spectrum (AVANCE III HD Bruker spectrometer) of PEG400-PA-mea ester-containing benzoxazine monomer.



FIG. 15 is displaying the DSC curve of the PEG400-PA-mea monomer. Conditions: 10° C. min−1, N2 atmosphere (Netzsch DSC 204 F1 Phoenix apparatus). The DSC curve shows an exothermic peak starting at a temperature of 132° C. for PEG400-PA-mea. This peak corresponds to the ring opening of the benzoxazine rings upon heating. The second peak corresponds to the thermal decomposition of the ester linkage.


The curing of the PEG400-PA-mea ester-containing benzoxazine monomer was monitored by rheological measurement in FIG. 16, to assess the mechanical behaviour of the monomers during the curing process.


The rheogram is performed under the following conditions: 1 Hz, with linear amplitude from 1 to 0.1%; 25 mm plates. The test is performed following a heating ramp from 80° C. to 140° C. at 15° C./min followed by an isothermal measurement at 140° C. The storage and loss modulus are recorded as a function of time. The term “gelation time” is defined as the time when the storage and the loss modulus of the soften monomer increases abruptly to transform into a gel. The gelation is defined by the crossover point between the storage and the loss modulus. At 140° C., the gelation time is reached after 27 min.


Example 6
Synthesis of a Vitrimer Obtained through the Curing of PEG400-PA-mea Ester-Containing Benzoxazine Monomers

The benzoxazine monomer obtained in Example 5 was polymerized in a Teflon mold at 150° C. during 1 h for the obtention of a PEG400-PA-mea derivatives polybenzoxazine vitrimer material.


Viscoelastic properties of poly(PEG400-PA-mea) vitrimer were studied by stress relaxation experiments (FIG. 17a)). The relaxation time of the polymer was clearly noticeable and proportionally decreasing upon heating from 120° C. (1131 s) to 170° C. (14 s).


The temperature dependence of the relaxation time was plotted following the Arrhenius law (FIG. 17b)). The trend line fits to a thermally activated behaviour for the relaxation time. The high correlation coefficient (R2=0.9901) means that these data are perfectly fitting the Arrhenius law. The activation energy from the Arrhenius equation was extracted using the slope of the trend line. The activation energy obtained from stress relaxation is 131 kJ·mol−1.

Claims
  • 1.-20. (canceled)
  • 21. An ester containing benzoxazine monomer of formula (I)
  • 22. The ester containing benzoxazine monomer according to claim 21, wherein: at least one R* group is present in the benzoxazine cycle, and the R* group is selected from the group consisting of H, an aliphatic C1-C4 alkyl group, OH, an aliphatic C1-C4 alkoxy group,
  • 23. A process for synthesizing an ester-containing benzoxazine monomer of formula (I) according to claim 21, comprising the following steps consisting of: a) reacting a phenolic acid derivative of formula (II), comprising at least one R* group,
  • 24. The process according to claim 23, wherein the phenolic acid derivative is selected from the group consisting of mono-, di-, tri-hydroxybenzoic acid derivatives, anacardic acid derivatives, hydroxycinnamic acid derivatives, aliphatic X-hydroxyphenyl acid derivatives, wherein X is 2-4, aliphatic diphenolic acid derivatives and triphenolic acid derivatives, or mixtures thereof.
  • 25. The process according to claim 24, wherein the aliphatic mono-, di-, tri-hydroxybenzoic acid derivatives are of formula (VI)
  • 26. The process according to claim 24, wherein the anacardic acid derivatives are of formula (VII), wherein R6═R*,
  • 27. The process according to claim 24, wherein the hydroxycinnamic acid derivatives are of formula (VIII)
  • 28. The process according to claim 24, wherein the aliphatic X-hydroxyphenyl acid derivatives are selected from the group consisting of aliphatic di-hydroxyphenyl acids (X=2), aliphatic tri-hydroxyphenyl acids (X=3) and aliphatic tetra-hydroxyphenyl acids (X=4) of formula (IX), or mixtures thereof
  • 29. The process according to claim 24, wherein the aliphatic diphenolic acid derivatives are of formula (X)
  • 30. The process according to claim 23, wherein the compound of formula (III) has p values of 1-30, and represents, when R′═H, a polyethylene glycol (PEG) with a molecular weight (MW) in the range of from 4 MW of the C2H4O unit to 50 MW of the C2H4O unit.
  • 31. The process according to claim 23, wherein the step a) is carried out at a temperature in the range of 60° C. to 150° C., and is performed from 12 h to 48 h.
  • 32. The process according to claim 23, wherein the respective stoichiometry of starting reactants on step a), phenolic acid derivative: olyfunctional molecule or oligomer is 1.0-3.0 eq.:1.0 eq., resulting in an 1.0 eq. of phenol terminated oligomer or molecule of formula (IV).
  • 33. The process according to claim 23, wherein the amino-alcohol bifunctional derivative of formula (V) includes a linear amino-alcohol derivative with a primary amine moiety and an aliphatic hydroxyl moiety, and is selected from the group consisting of 2-aminoethanol, 2-amino-2-methylpropanol, 5-aminopentan-1-ol, heptaminol and diglycolamine.
  • 34. The process according to claim 23, wherein the aldehyde derivative is selected from the group consisting of formaldehyde, paraformaldehyde of formula
  • 35. The process according to claim 23, wherein step b) is performed without any catalyst.
  • 36. The process according to claim 23, wherein, when step b) includes at least one catalyst, said least one catalyst is selected from the group consisting of Zn(II)(R10)2 wherein R10 is Cl−, CH3CO2−, CH3—C(═O)—O−, CH3COCHCOCH3−, CH3(CH2)r:1-15CH2CO2−; triazobicyclodecene (TBD); triphenylphosphine (PPh3) and para-toluene sulfonic acid (APTS).
  • 37. The process according to claim 23, wherein the respective stoichiometry of starting reactants on step b), phenol terminated oligomer or molecule: amino-alcohol bifunctional derivative:aldehyde derivative is 1.0 eq.:1.0-18.0 eq.:2.0-36.0 eq., resulting in an 1.0 eq. of the ester-containing benzoxazine monomer.
  • 38. A process for preparing polybenzoxazine derivative vitrimers comprising the step of polymerization of an ester-containing benzoxazine monomer of claim 21, at temperatures within the range of from 100° C. to 250° C. for 1 h to 24 h.
  • 39. A polybenzoxazine derivative vitrimer, that may be obtained by the process according to claim 38, exhibiting at least one of the following characteristics: (i) Tv values of from 120° C. to 220° C.; and(ii) Relaxation temperature values, ≥Tv values, of from 120° C. to 270° C.
  • 40. The polybenzoxazine derivative vitrimer according to claim 39, exhibiting at least one of the following characteristics selected from the group consisting of: a relaxation time of from 0.5 s to 2 h;an activation energy related to relaxation times of from 50 kJ/mol to 200 kJ/mol; anda processing temperature of from 100° C. to 250° C.
Priority Claims (1)
Number Date Country Kind
LU 101846 Jun 2020 LU national
CROSS-REFERENCE TO RELATED APPLICATIONS

The present invention is the US national stage under 35 U.S.C. § 371 of International Application No. PCT/EP2021/065335 which was filed on Jun. 8, 2021, and which claims the priority of application LU101846 filed on Jun. 10, 2020 the contents of which (text, drawings and claims) are incorporated here by reference in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/EP2021/065335 6/8/2021 WO